利用急诊科触发工具识别高风险阿片类药物给药相关不良事件
本研究为急诊科触发工具(EDTT)的多中心回顾性二次分析,针对两个触发条件:M2(≥3剂氢吗啡酮给药)和M18(阿片类+苯二氮䓬类给药)。在三个中心18个月数据中,13,601/450,852次就诊(3.0%)符合至少一个触发条件。在8,719份抽样记录中,458份(5.3%)包含触发条件;其中120次触发就诊共识别出124例阿片相关急诊不良事件(26.2%)。常见不良事件包括低血压、缺氧、过敏反应和谵妄,多数导致暂时性伤害,但30%需要紧急干预。EDTT是检测不良事件的有效方法,聚焦高风险阿片给药的触发条件作为监测策略可能具有更有利的产出。
要点
- 三个中心18个月数据中,13,601/450,852次就诊(3.0%)符合高风险阿片触发条件:M2(≥3剂氢吗啡酮)1.4%,M18(阿片类+苯二氮䓬类)1.4%,两者兼有0.2%。
- 抽样8,719份记录中,458份(5.3%)含触发条件;120次触发就诊共识别124例阿片相关急诊不良事件(26.2%)。
- M2触发就诊中阿片相关不良事件47.4%(37/78),M18为21.9%(76/347),两者兼有为21.2%(7/33)。
- 常见不良事件包括低血压、缺氧、过敏反应和谵妄,多数导致暂时性伤害,但30%需要紧急干预。
- 各中心阿片相关急诊不良事件检出率无差异;EDTT是检测不良事件的有效方法,聚焦高风险阿片给药的触发条件作为监测策略可能具有更有利的产出。
适用人群与场景
- 急诊科就诊患者中接受高风险阿片类药物给药者,触发条件为M2(≥3剂氢吗啡酮给药)或M18(阿片类+苯二氮䓬类给药)。
诊断标准与关键阈值
- 触发条件M2:≥3剂氢吗啡酮给药。
- 触发条件M18:阿片类+苯二氮䓬类给药。
研究设计与关键结果
- 研究类型:多中心回顾性研究的二次分析,应用急诊科触发工具(EDTT)于三个中心18个月数据提取,采用两级方法审查每中心约3000份记录的平衡样本。
- 触发条件分布:13,601/450,852次就诊(3.0%)符合至少一个触发条件;M2为6,447次(1.4%),M18为6,201次(1.4%),两者兼有为853次(0.2%)。
- 抽样记录:8,719份记录中,458份(5.3%)含至少一个触发条件(M2 78份,M18 347份,两者兼有33份);审查者一致性高(Kappa=0.94)。
- 主要结果:120次触发就诊中识别124例阿片相关急诊不良事件(26.2%);M2触发就诊中37/78(47.4%),M18中76/347(21.9%),两者兼有中7/33(21.2%)。
- 各中心阿片相关急诊不良事件检出率无差异;常见不良事件包括低血压、缺氧、过敏反应和谵妄,多数导致暂时性伤害,但30%需要紧急干预。
证据类型、等级与局限
- 证据类型:多中心回顾性研究的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 急诊科触发工具可用于检测高风险阿片类药物给药相关不良事件;触发条件M2和M18的产出可能有助于监测策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Opioid-related adverse events (AEs) resulting in or following an ED visit are well described. Less is known about AEs due to opioid administration in the ED, whose detection is limited by the high frequency of administration and poorly specific surveillance methods. We studied the use of the ED Trigger Tool (EDTT) for detection of AEs from high-risk opioid administration in the ED.
METHODS: This is a secondary analysis of a multicenter retrospective study of the EDTT for two selected triggers: M2- ≥ 3 doses of hydromorphone administered and M18- opioid + benzodiazepine administration. We applied the EDTT to an 18-month extract of data from three sites and reviewed a balanced sample of ~3000 records/site using a two-tiered approach, characterizing opioid-related AEs by occurrence, type, and severity. Analysis is descriptive.
RESULTS: A total of 13,601/450,852 visits (3.0%) across three sites included one of these triggers: M2 (6447; 1.4%); M18 (6201; 1.4%); or both (853; 0.2%). In our sample of 8719 records, 458 (5.3%) included at least one of these triggers (78 with M2, 347 with M18, and 33 with both). Reviewer agreement was high (Kappa = 0.94). We identified 124 opioid-related ED AEs among 120 triggered visits (26.2%): M2 (37/78 visits; 47.4%); M18 (76/347 visits; 21.9%), and both (7/33 visits; 21.2%). There were no site differences in opioid-related ED AE detection. Common AEs included hypotension, hypoxia, allergic reactions, and delirium, mostly resulting in temporary harm but 30% requiring urgent intervention.
CONCLUSIONS: In our sample, 5% of visits included high-risk opioid administration, of which 26% included an opioid-related AE. AE rates were similar across sites, with expected variability in type and severity across triggers and sites. The EDTT is a useful approach for AE detection. Triggers focusing on high-risk opioid administration may have a more favorable yield as a surveillance strategy.
参考来源
- Griffey RT, Bollam N, Schneider RM, et al. Identifying Adverse Events Associated With High-Risk Opioid Administration Using the Emergency Department Trigger Tool. Acad Emerg Med. 2026. PMID: 41689235. doi:10.1111/acem.70216
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。